Investigating the Effectiveness of Uthever for Promoting Healthy Aging

With this in mind, scientists at EffePharm in Shanghai assessed the safety and effectiveness of Uthever, an anti-aging supplement. Uthever is the brand name for a natural compound called NMN, which is converted to NAD in our bodies.

NAD is an important molecule in a large range of crucial biological processes, but it becomes depleted during aging. Depleted NAD is associated with age-related diseases, such as cancer, metabolic disorders and neurological disorders. The idea behind using Uthever as a supplement is to reduce the negative effects of age-related NAD depletion.

At least, that’s the theory. The EffePharm scientists put it to the test in a clinical trial with 66 healthy participants between the ages of 40 and 65 years. The participants took two capsules, each containing 150 milligrams of Uthever once a day for 60 days, while a control group took two starch capsules instead.

Strikingly, blood levels of NAD, and those of a closely related metabolite, were increased in the Uthever group by 11.3% by day 30 and 38% by day 60. The Uthever group also demonstrated a 6.5% improvement in a 6-minute walking endurance test by day 60, compared with 3.9% in the control group, suggesting that these participants had increased energy levels.   

The Uthever group also demonstrated small increases in wellbeing, as measured using a questionnaire. The researchers also assessed the participants’ insulin resistance, an early stage of type 2 diabetes. The Uthever groups showed no significant effect on blood sugar and insulin levels, so the treatment was well tolerated and appears to be safe at this dose.

Overall, the study found that Uthever has potential in positively affecting several aspects of aging.

As more and more clinical studies on the safety and efficacy of this supplement are published, the EffePharm scientists believe that Uthever will be a welcome tool in our arsenal against age-related health deterioration.